Clinuvel Pharmaceuticals
CUV.AX
#7625
Rank
ยฃ0.28 B
Marketcap
ยฃ5.61
Share price
-2.22%
Change (1 day)
-7.13%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2025: ยฃ45.67 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ45.67 Million. In 2025 the company made a revenue of ยฃ45.67 Million an increase over the revenue in the year 2024 that were of ยฃ43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2025

Annual revenue

Year Revenue Change
2025ยฃ45.67 M6.21%
2024ยฃ43 M12.75%
2023ยฃ38.13 M15.14%
2022ยฃ33.12 M26.03%
2021ยฃ26.28 M60.04%
2020ยฃ16.42 M3.08%
2019ยฃ15.93 M15.58%
2018ยฃ13.78 M46.97%
2017ยฃ9.38 M177.46%
2016ยฃ3.38 M106.53%
2015ยฃ1.63 M7.98%
2014ยฃ1.51 M46.33%
2013ยฃ1.03 M91.51%
2012ยฃ0.54 M-33.65%
2011ยฃ0.81 M
2010N/A
2009N/A
2008N/A-100%
2007ยฃ0.17 M-57.04%
2006ยฃ0.4 M487.15%
2005ยฃ0.06 M
2004N/A
2002N/A
2001N/A